Adipo Therapeutics completes $1.9M seed funding bridge to advance obesity and Type 2 diabetes treatment
Amount Raised
$1.9 Million
Round Type
Seed
Investors
Description
Adipo Therapeutics has successfully completed a $1.9 million seed funding bridge to advance obesity and Type 2 diabetes treatment. The company will embark on raising $35M Series A financing.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Adipo Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Crinetics Pharmaceuticals raised $350M on March 1, 2024.
- Parabilis Medicines raised $145M (Series E) on March 1, 2024.
- Denali Therapeutics raised $500M on February 29, 2024.
- vTv Therapeutics Inc. raised $51M on February 27, 2024.
- IsomAb raised $7.5M (Seed) on February 20, 2024.
- HCW Biologics raised $2.5M (Seed) on February 20, 2024.
Who to call at Adipo Therapeutics, and when
A new round usually means Adipo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Adipo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adipo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adipo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adipo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Adipo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.